Bionano Genomics Inc (BNGO)

Jan 6, 2025, 4:30 PM EST - 11 days ago

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 2:34 PM EST - 14 days ago

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Dec 31, 2024, 3:26 PM EST - 17 days ago

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Dec 23, 2024, 8:30 AM EST - 25 days ago

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Nov 13, 2024, 7:11 PM EST - 2 months ago

Bionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 2 months ago

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Nov 4, 2024, 4:14 AM EST - 2 months ago

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Oct 31, 2024, 4:30 PM EDT - 2 months ago

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Oct 31, 2024, 8:10 AM EDT - 2 months ago

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Oct 10, 2024, 8:00 AM EDT - 3 months ago

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

Aug 13, 2024, 7:23 PM EDT - 5 months ago

Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)

Aug 7, 2024, 7:11 PM EDT - 5 months ago

Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:01 PM EDT - 5 months ago

Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress

Jul 31, 2024, 4:01 PM EDT - 6 months ago

Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 8, 2024, 5:25 PM EDT - 6 months ago

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 5, 2024, 8:00 AM EDT - 7 months ago

Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 2, 2024, 8:00 AM EDT - 7 months ago

Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations

Jun 20, 2024, 8:00 AM EDT - 7 months ago

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

Jun 17, 2024, 4:05 PM EDT - 7 months ago

Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis

May 23, 2024, 9:17 AM EDT - 8 months ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA CTKB DHR LAB MASS OMIC QGEN

May 8, 2024, 7:12 PM EDT - 9 months ago

Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 9 months ago

Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress

Apr 11, 2024, 8:00 AM EDT - 10 months ago

Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing

Apr 4, 2024, 1:44 PM EDT - 10 months ago

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Apr 3, 2024, 8:00 AM EDT - 10 months ago

Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics

Mar 7, 2024, 8:00 AM EST - 11 months ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys™ System

Mar 5, 2024, 9:54 PM EST - 11 months ago

Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 4:01 PM EST - 11 months ago

Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024

Feb 29, 2024, 8:00 AM EST - 11 months ago

Bionano to Present at TD Cowen's 44th Annual Health Care Conference

Feb 28, 2024, 8:01 AM EST - 11 months ago

Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024

Feb 28, 2024, 8:00 AM EST - 11 months ago

Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway

Jan 31, 2024, 8:00 AM EST - 1 year ago

Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 24, 2024, 8:00 AM EST - 1 year ago

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

Jan 23, 2024, 8:00 AM EST - 1 year ago

Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping

Jan 19, 2024, 8:00 AM EST - 1 year ago

Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

Jan 11, 2024, 4:01 PM EST - 1 year ago

Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing

Jan 10, 2024, 8:00 AM EST - 1 year ago

Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

Jan 8, 2024, 8:00 AM EST - 1 year ago

Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results

Jan 3, 2024, 8:00 AM EST - 1 year ago

International Consortium Publishes Comprehensive Roadmap for the Clinical Implementation of OGM in Hematological Malignancy Applications

Jan 3, 2024, 8:00 AM EST - 1 year ago

OGM Added to International System for Human Cytogenomic Nomenclature

Dec 28, 2023, 8:00 AM EST - 1 year ago

Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA™ Software for OGM Data Analysis in Constitutional Genetic Disease Research

Dec 26, 2023, 8:00 AM EST - 1 year ago

Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping

Dec 14, 2023, 8:00 AM EST - 1 year ago

Cancers Journal Publishes Special Issue Dedicated to OGM's Impact on Hematological Malignancy Research

Nov 30, 2023, 8:00 AM EST - 1 year ago

Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD

Nov 29, 2023, 10:04 AM EST - 1 year ago

Bionano Announces Publication Demonstrating Utility of OGM to Assess Genome Integrity of CRISPR-Edited Cells as Part of Gene Therapy Development

Nov 15, 2023, 3:23 PM EST - 1 year ago

Bionano Genomics, Inc. (BNGO) Presents at Stifel Healthcare Conference (Transcript)

Nov 14, 2023, 8:00 AM EST - 1 year ago

Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting

Nov 8, 2023, 6:58 PM EST - 1 year ago

Bionano Genomics, Inc. (BNGO) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:01 PM EST - 1 year ago

Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress

Nov 1, 2023, 8:00 AM EDT - 1 year ago

Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023